article thumbnail

NHC Submits Comments on CMS’ Proposed Rule on Marketplace Integrity and Affordability

Putting Patients First Blog

While we recognize CMS intent to strengthen program integrity and reduce fraud, we are deeply concerned that several provisions in this rule will create obstacles to coverage, increase out-of-pocket costs, and disproportionately impact vulnerable populations.

article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

In 2020, we saw seven of the 20 biosimilars currently available in the US launch. The United States biosimilar market experienced a significant increase in competition in 2020. As a result of the regulatory changes that occurred in March 2020, the first potential insulin biosimilar is on the horizon. million patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Kaia Health gets $75m for digital solution to strains and pains of pandemic workplace

pharmaphorum

To say that Kaia Health has had a busy 2020 is an understatement. Officially launched in 2016, Kaia’s technology can now be accessed by 60 million patients worldwide and it claims to be the biggest player in digital MSK in terms of coverage. The benefits of insurance firms are focused on main HQ offices.”. About the author.

article thumbnail

NHC’s comments in response to the 2025 Notice of Benefit and Payment Parameters (NBPP)

Putting Patients First Blog

Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.

article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

In January 2020, the financial conglomerate Visa announced it was acquiring a relatively unknown startup, Plaid, for $5.3 Corporate acquisitions like these are not uncommon, but someone at the United States Department of Justice took notice of this announcement. Visa had established a stranglehold on financial transactions.

HIPAA 98
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Medicare Part A, Part B, and Part D do not generally cover approved weight loss medications like Saxenda, but Medicare Advantage plans may allow for expanded coverage, as per the Medicare.org site.

article thumbnail

MTHFR, Hashimoto’s and Nutrients

The Thyroid Pharmacist

4] One of the key things to note is that this gene variation also prevents people from properly methylating, which is one of the body’s key detox processes that helps them get rid of toxins. But a 2020 study of 34 women with hypothyroidism actually found that the MTHFR gene variant is significantly associated with hypothyroidism. [11]